back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-10-07 20:47 Tx date 2026-10-01 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-85,710
-17,142 vol $5.00 each |
13,683 | |
| Older filings | ||||||
| Filed 2026-09-23 22:00 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-509,575.56
-100,508 vol $5.07 each |
30,825 | |
| Filed 2026-09-23 21:49 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-418,401.75
-82,525 vol $5.07 each |
48,808 | |
| Filed 2026-09-23 21:49 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-418,401.75
-82,525 vol $5.07 each |
||
| Filed 2026-09-23 21:49 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$334,112
+78,800 vol $4.24 each |
131,333 | |
| Filed 2026-09-23 21:48 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$175,460
+52,533 vol $3.34 each |
52,533 | |
| Filed 2026-09-23 21:47 Tx date 2025-08-04 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-09-23 21:46 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-175,460.22
-52,533 vol $3.34 each |
105,067 | |
| Filed 2026-09-23 21:45 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-334,112
-78,800 vol $4.24 each |
157,600 | |
| Filed 2026-06-11 06:48 Tx date 2026-06-08 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$334,112
+78,800 vol $4.24 each |
236,400 | |
| Filed 2025-08-06 16:16 Tx date 2025-08-04 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$526,384
+157,600 vol $3.34 each |
157,600 | |
| Filed 2025-08-06 14:59 Tx date 2025-08-04 |
$ABUS
Arbutus Biopharma Corporation |
Sawhney, Roger
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||